Hims & Hers Health, Inc. 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Market Information Our Class A common stock trades on the New York Stock Exchange (“NYSE”) under the symbol “HIMS”. Holders On February 23, 2024 , there were 129 holders of record of our Class A common stock. Because many of our shares of Class A common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders. However, we believe a substantially greater number of beneficial owners hold shares of our Class A common stock through brokers, banks, or other nominees. Dividends We have not paid any cash dividends on our Class A common stock to date. The payment of any cash dividends is within the discretion of our Board and our Board does not currently contemplate declaring any dividends in the foreseeable future. Securities Authorized for Issuance under Equity Compensation Plans The information concerning our equity compensation plans is incorporated by reference herein to the section of the 2024 Proxy Statement entitled “Equity Compensation Plan Information.” Issuer Purchases of Equity Securities Share repurchase activity during the three months ended December 31, 2023 was as follows (in thousands, except share and per share data): Total Number of Shares of Class A Common Stock Purchased Average Price Paid per Share (1) Total Number of Shares Purchased as Part of the Publicly Announced Program Approximate Dollar Value of Shares That May Yet Be Purchased Under the Publicly Announced Program (2) October 1, 2023 to October 31, 2023 — $ — — November 1, 2023 to November 30, 2023 237,458 $ 8.42 237,458 December 1, 2023 to December 31, 2023 — $ — — Total repurchases 237,458 $ 48,001 ______________ (1) Average price paid per share includes costs associated with the repurchases. (2) On November 6, 2023, we announced that our Board of Directors had authorized a repurchase program, pursuant to which we may repurchase up to $50.0 million of our Class A common stock through open market purchases, privately negotiated transactions or other means, including through 10b5-1 trading plans As of December 31, 2023, approximately $2.0 million of our shares had been repurchased under the authorization. The repurchase program expires on November 8, 2025. Stock Performance Graph The following graph compares the cumulative total return to stockholders on our Class A common stock relative to the cumulative total returns of the Nasdaq Internet Index, the S&P 500 Health Care Sector Index, and the Russell 2000 Index. An investment of $100 (with reinvestment of all dividends) is assumed to have been made in our Class A common stock and in each index on January 21, 2021, the date our Class A common stock began trading on the NYSE, and its relative performance is tracked through December 31, 2023. The returns shown are based on historical results and are not intended to suggest future performance. 48 Table of Contents Item 6. [Reserved]